Albertsons shoppers are walking past the produce aisle in growing numbers, choosing shelf-stable goods over fresh fruits and vegetables, a shift that compounds an already grim financial picture for one of America's largest grocery chains. The company's own filings show produce sales have dipped even as CEO Susan Morris touts a pivot toward pharmacy revenue and e-commerce growth.
The trend is not just an Albertsons problem. It reflects broader consumer behavior driven by tighter household budgets, the rise of GLP-1 weight-loss medications, and a post-pandemic recalibration of how Americans eat. But at Albertsons, the numbers tell a story of a company struggling to hold its footing after a failed $24.6 billion merger with Kroger, ballooning debt, and an operating income that cratered by half in a single fiscal year.
Fresh produce and nonperishable food still account for the bulk of Albertsons' revenue. But overall growth in those categories slowed from the prior year, as The Sun reported. Shoppers are gravitating toward longer-lasting items, canned goods, frozen foods, pantry staples, that stretch a dollar further and don't rot on the counter.
Albertsons executives had previously committed to clearing shelves of moldy and subpar produce, an acknowledgment that quality problems were driving customers elsewhere. Competitors like Trader Joe's and Sprouts have picked up defecting shoppers, according to the same reporting.
Analytics platform Placer.ai tied the shift partly to a health-and-wellness trend that has been building for years but recently accelerated alongside the explosion in GLP-1 drug use. As Placer.ai put it:
"While this pivot has been underway for several years, reflecting a broader post-pandemic focus on health and wellness, its recent acceleration coincides with the rise in GLP-1 use."
That's a polite way of saying that millions of Americans on Ozempic and Mounjaro are simply eating less, and buying less food. For a grocery chain already losing ground, fewer items in the cart is the last thing the balance sheet needs.
Albertsons posted a 3.5 percent sales increase in its most recent fiscal year. On paper, that sounds respectable. Underneath, the numbers are far less encouraging.
Operating income fell 50 percent over the same period. Debt climbed 8 percent, reaching $8.4 billion. E-commerce sales rose 21 percent, a bright spot, but online grocery is a low-margin business that rarely compensates for collapsing in-store profitability.
The company's 1,700-plus pharmacies now generate 13.7 percent of total revenue, and Morris made clear on a recent earnings call that pharmacy is where she sees the future. Grocery shoppers already face wide price variation depending on which chain they choose, and Albertsons appears to be betting that filling prescriptions, not selling apples, will keep customers walking through the door.
Morris framed the strategy this way on the call:
"This performance reinforces our confidence in our strategy to improve pharmacy stand-alone profitability, while also driving materially higher customer lifetime value among customers who shop both pharmacy and grocery."
Translation: Albertsons wants to lock in customers who pick up medications and then grab groceries on the way out. It's a reasonable play. But when the grocery side of the house is hemorrhaging operating income and produce quality is chasing shoppers to competitors, the "lifetime value" proposition gets harder to sell.
None of this is happening in a vacuum. Albertsons spent years pursuing a $24.6 billion merger with Kroger that regulators ultimately blocked over antitrust concerns and fears of higher consumer prices. The deal's collapse left Albertsons standing alone, carrying the legal costs and strategic disruption of a failed mega-merger with nothing to show for it.
In 2024, Albertsons sued Kroger, alleging breach of contract. The lawsuit settled out of court, though the specific terms have not been disclosed. Meanwhile, Albertsons closed two stores in Fort Worth, Texas, part of a broader operational tightening that followed the merger's failure.
The company has also dealt with legal headaches on other fronts. Albertsons-owned Safeway reached a $5.95 million class action settlement over alleged violations of the federal Telephone Consumer Protection Act. Separately, Albertsons, Costco, and Safeway paid a combined $1 million settlement involving California contractors.
Albertsons' troubles land in the middle of a punishing stretch for American retail. Financial firm UBS has predicted 45,000 store closures across the U.S. retail sector over the next five years, projecting the total number of retail outlets to fall from roughly 958,000 to 913,000.
The carnage is already visible. Foot Locker announced in 2023 that it would shutter up to 400 locations by 2026. Tuesday Morning and Mitchell Gold + Bob Williams both filed for bankruptcy that same year. Since 2019, the hardest-hit categories have included clothing, consumer electronics, sporting goods, and home furnishing stores.
Grocery has historically been more resilient, people have to eat. But the Albertsons data suggests that even food retailers are not immune when consumers tighten spending, competitors sharpen their offerings, and new health trends reshape what goes into the shopping cart. Family Dollar's wave of store closures is another reminder that budget-conscious Americans will abandon any chain that fails to deliver value.
Several important questions remain unresolved. The company has not disclosed the precise dollar amount or percentage of its produce sales decline. It has not detailed which locations are hardest hit or whether the problem is concentrated in certain regions. The timeline for its produce-quality improvement initiative remains vague.
It is also unclear how much of the 50 percent operating income drop stems directly from the failed Kroger merger, legal fees, transition costs, strategic drift, versus the underlying retail headwinds hitting the entire sector. Consumer trust is fragile, and Albertsons has given shoppers little reason to stick around when Trader Joe's and Sprouts are a short drive away.
Morris's pharmacy-first strategy may prove shrewd over time. Prescription drugs are a recurring-revenue business with built-in customer retention. But a grocery chain that can't keep its produce fresh and its operating income stable is a grocery chain betting its future on a business it wasn't built to run.
When the fresh food aisle empties out, so does the argument that everything is fine.